RBC Capital Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Underperform
Tweet Send to a FriendGet Alerts ENDP Hot Sheet
Price: $34.04 +0.92%
Rating Summary:
7 Buy, 11 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
7 Buy, 11 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade ENDP Now!
RBC Capital downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Sector Perform to Underperform with a price target of $24.00 (from $25.00).
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $31.00 yesterday, with a 52 week range of $25.01-$39.29.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $31.00 yesterday, with a 52 week range of $25.01-$39.29.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Sterne Agee Downgrades Beazer Homes (BZH) to Neutral
- Macquarie Downgrades CME Group (CME) to Neutral
- Goldman Sachs Downgrades WellCare Health Plans (WCG) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
RBC Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
